Author

Haibo Mou

Observed names: H. B. Mou, H.B Mou, H.B. Mou, HAIBO MOU, Mou, H.

Observed institutions: Zhejiang Shuren University, First Affiliated Hospital Zhejiang University, Zhejiang University

ORCID: 0000-0002-6306-2167

Observed ORCID: 0000-0002-6306-2167

OpenAlex ID: A5004901295

Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways

2011 · Haibo Mou, Yi Zheng, et al. · Toxicology in Vitro · 97

Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: a case report

2018 · Haibo Mou, Lanfang Yu, et al. · BMC Cancer · 67

PDF

Prognostic Significance of COX-2 Immunohistochemical Expression in Colorectal Cancer: A Meta-Analysis of the Literature

2013 · Ling Peng, Yun Zhou, et al. · PLoS ONE · 66

PDF

Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy

2021 · Lin Tian, Anhua Lei, et al. · Kidney Diseases · 42

PDF

CircRNA_100395 Carried by Exosomes From Adipose-Derived Mesenchymal Stem Cells Inhibits the Malignant Transformation of Non-Small Cell Lung Carcinoma Through the miR-141-3p-LATS2 Axis

2021 · Chong Zhang, Jinlin Cao, et al. · Frontiers in Cell and Developmental Biology · 42

PDF

Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response

2020 · Jingjing Li, Qing Wei, et al. · Clinical and Translational Medicine · 24

Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry (1988–2013)

2018 · Haibo Mou, Qin Liao, et al. · International Journal of Radiation Biology · 24

Preliminary Evaluation of Atezolizumab Plus Bevacizumab as Salvage Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation

2022 · Zhe Yang, Jingqi Sun, et al. · Liver Transplantation · 22

Primary primitive neuroectodermal tumor of the urinary bladder: a case report and literature review

2010 · Yulong Zheng, Fuqing Tan, et al. · Medical Oncology · 17

Transforming Growth Factor-β1 Modulates Lipopolysaccharide-Induced Cytokine/Chemokine Production and Inhibits Nuclear Factor-κB, Extracellular Signal-Regulated Kinases and p38 Activation in Dendritic Cells in Mice

2011 · H.B. Mou, M.F. Lin, et al. · Transplantation Proceedings · 14

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

2006 · N. Xu, P. Shen, et al. · Cancer Chemotherapy and Pharmacology · 13

Nomogram for Predicting Survival Post-Immune Therapy in Cholangiocarcinoma Based on Inflammatory Biomarkers

2024 · Jianan Jin, Haibo Mou, et al. · Cancer Control · 9

Programmed cell death‐ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics

2021 · Haibo Mou, Qiu‐an Yang, et al. · Journal of Gastroenterology and Hepatology · 9

PDF

The relationship between epigenetic biomarkers and the risk of diabetes and cancer: a machine learning modeling approach

2025 · Shiqi Zhang, Jianan Jin, et al. · Frontiers in Public Health · 8

Prevention of murine acute graft-versus-host disease by recipient-derived TGFβ1-treated dendritic cells

2004 · H.B Mou, M.F Lin, et al. · Transplantation Proceedings · 7

Phase Ib study of the oral PI3Kδ inhibitor linperlisib in patients with advanced solid tumors

2024 · Jin Li, Junli Xue, et al. · International Journal of Clinical Oncology · 6

PDF

Case report: Long-term clinical benefit of pyrotinib therapy following trastuzumab resistance in HER2-amplification recurrent mucinous ovarian carcinoma

2022 · Xiangming Fang, Haibo Mou, et al. · Frontiers in Oncology · 6

PDF

Pemigatinib in Chinese patients with advanced/metastatic or surgically unresectable cholangiocarcinoma including FGFR2 fusion or rearrangement: Updated data from an open-label, single-arm, multicenter phase II study (CIBI375A201 study).

2022 · Guoming Shi, Xiaoyong Huang, et al. · Journal of Clinical Oncology · 6

Effect of Postoperative Radiotherapy in Thymoma Patients: A SEER-Based Study

2020 · Haibo Mou, Yiyao Kong, et al. · Oncology Research and Treatment · 6

Efficacy and safety of apatinib in refractory unresectable and metastatic cholangiocarcinoma: A retrospective analysis.

2018 · Haibo Mou, Qinfen Xie, et al. · Journal of Clinical Oncology · 5

Complete remission of platinum-refractory primary Fallopian tube carcinoma with third-line gemcitabine plus cisplatin: A case report and review of the literature

2013 · QIUYI XU, NONG XU, et al. · Oncology Letters · 5

PDF

Case report: A case of complete clinical response in a patient experiencing high microsatellite instability unresectable colon cancer being treated with a PD-L1 inhibitor after interstitial pneumonia

2023 · Luo Wang, Haibo Mou, et al. · Frontiers in Oncology · 4

PDF

A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer

2015 · Haiping Jiang, Jiong Qian, et al. · Cancer Chemotherapy and Pharmacology · 4

Complete remission in a patient with advanced renal pelvis carcinoma with lung metastasis treated with durvalumab immunotherapy: a case report

2020 · Yingfang Wu, Haibo Mou · Annals of Palliative Medicine · 3

PDF

A phase Ib study of the PI3Kδ inhibitor linperlisib in patients with advanced solid tumors.

2021 · Jin Li, Nong Xu, et al. · Journal of Clinical Oncology · 1

Works count: 42

Citation count: 509

H-index: 11

I10-index: 11